High-Density Lipoprotein (HDL) Modulation and Endothelial Function

Clinical trial NCT00150722 · COMPLETED

Trial details

NCT number: NCT00150722
Sponsor: University of Calgary
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2005-09-01
Primary completion: 2008-08-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.